JAC Advance Access originally published online on May 13, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 1373-1376
© 2003 The British Society for Antimicrobial Chemotherapy
Improving the mouse model for studying the efficacy of voriconazole
1 The University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Infectious Diseases (7881), 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA; 2 Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, N.L., Mexico
Received 19 February 2003; accepted 12 March 2003
Outbred ICR mice were rendered neutropenic, infected intravenously with Fusarium solani and treated orally with voriconazole. When given alone, voriconazole was not protective up to 40 mg/kg/day. When grapefruit juice was administered before infection, mice were protected by voriconazole. The mechanism may be inhibition of gut mucosal cytochrome enzymes that rapidly degrade voriconazole in the mouse. These murine studies support expansion of voriconazole therapy in other highly resistant systemic mycoses.
Keywords: voriconazole, mice, grapefruit juice
* Corresponding author. Tel: +1-210-567-0990; Fax: +1-210-567-0962; E-mail: jrgraybill{at}aol.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-I. Kang, M. S. Rouse, J. N. Mandrekar, J. M. Steckelberg, and R. Patel Anidulafungin Treatment of Candidal Central Nervous System Infection in a Murine Model Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3576 - 3578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. J. van de Sande, R. A. A. Mathot, M. T. ten Kate, W. van Vianen, M. Tavakol, B. J. A. Rijnders, and I. A. J. M. Bakker-Woudenberg Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2005 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruiz-Cendoya, M. Marine, and J. Guarro Combined therapy in treatment of murine infection by Fusarium solani J. Antimicrob. Chemother., September 1, 2008; 62(3): 543 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Kirkpatrick, L. K. Najvar, R. Bocanegra, T. F. Patterson, and J. R. Graybill New Guinea Pig Model of Cryptococcal Meningitis Antimicrob. Agents Chemother., August 1, 2007; 51(8): 3011 - 3013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Serena, F. J. Pastor, M. Marine, M. M. Rodriguez, and J. Guarro Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection J. Antimicrob. Chemother., July 1, 2007; 60(1): 162 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Spellberg, J. Schwartz, Y. Fu, V. Avanesian, J. Adler-Moore, J. E. Edwards Jr, and A. S. Ibrahim Comparison of antifungal treatments for murine fusariosis J. Antimicrob. Chemother., November 1, 2006; 58(5): 973 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. V. Clemons, M. Espiritu, R. Parmar, and D. A. Stevens Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4867 - 4875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Capilla and J. Guarro Correlation between In Vitro Susceptibility of Scedosporium apiospermum to Voriconazole and In Vivo Outcome of Scedosporiosis in Guinea Pigs Antimicrob. Agents Chemother., October 1, 2004; 48(10): 4009 - 4011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Capilla, C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro Efficacy of Voriconazole in Treatment of Systemic Scedosporiosis in Neutropenic Mice Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3976 - 3978. [Abstract] [Full Text] [PDF]
|
|